Home
Conditions
Advanced Melanoma

Clinical trial condition

Advanced Melanoma

Explore clinical trials studying Advanced Melanoma. Study availability and eligibility vary by location and protocol.

70 public trials 21 recruiting studies

Refine in advanced search Browse all conditions

Advanced Melanoma trial results

Recruiting

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)

NCT05663775

Conditions: Advanced Melanoma, Advanced Rectal Carcinoma, Diarrhea, +4 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Not yet recruiting

Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer

NCT07836712

Conditions: Adenocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Melanoma, +23 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not yet recruiting

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

NCT07819474

Conditions: Advanced Melanoma, CD8-PET, Tumor Infiltrating Lymphocyte
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Not yet recruiting

iSCIB1+ in Combination With Ipilimumab and Nivolumab as First-Line Treatment for Advanced Unresectable Melanoma

NCT07815574

Conditions: Advanced Melanoma, Melanoma, Melanoma (Skin Cancer), +13 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Mount Vernon Cancer Centre London, United Kingdom

View Trial Details

Not yet recruiting

MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.

NCT07574047

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations: HFR Fribourg Fribourg, Canton of Fribourg, Switzerland

Ente Ospedaliero Cantonale (EOC) Bellinzona, Switzerland

Inselspital, Bern Bern, Switzerland

Hôpitaux Universitaires de Genève HUG Geneva, Switzerland

View Trial Details

Not yet recruiting

A Clinical Study of BT02 for the Treatment of Patients With Advanced Malignant Melanoma

NCT07107178

Conditions: Advanced Melanoma, Advanced Solid Tumor
Locations: Not specified

View Trial Details

Not yet recruiting

Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1

NCT07040436

Conditions: Advanced Melanoma, Melanoma, Neoplasms, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study

NCT07004335

Conditions: Advanced Melanoma, Bevacizumab, CTLA-4, +4 more
Locations: The Fourth Hospital of Hebei Medical University Shijiazhuang, China

View Trial Details

Enrolling by invitation

HS-IT101 Injection in the Treatment of Advanced Melanoma

NCT06941818

Conditions: Advanced Melanoma
Locations: Peking University Cancer Hospital Beijing, China

View Trial Details

Active, not recruiting

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

NCT04462406

Conditions: Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +8 more
Locations: Thomas Hospital Fairhope, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

Fairbanks Memorial Hospital Fairbanks, Alaska, United States

Cancer Center at Saint Joseph's Phoenix, Arizona, United States

View all 482 locations

View Trial Details

Advanced Melanoma

Advanced Melanoma trial results

Related conditions